RxDoctor Payments Data

Karen Horton

Plastic Surgery · San Francisco, CANPI 1164463881

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 67.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $5,675 and has fallen 83.5% since, to $938 in 2025.

$15,083in general payments, 2019–2025

Across 192 payments — averaging $78.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$10K
  • Sientra, Inc.$3K
  • Axogen$268
  • Galderma Laboratories, L.p.$252
  • Mentor Worldwide LLC$244
  • BD$214
  • plus $518 from 8 others

What the payments were for

  • Consulting fees$4,33629%
  • Speaking & faculty fees$1,0917%
  • Travel & lodging$8105%
  • Food & beverage$8,84659%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,083 in reported general payments places this provider in the 85th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California →

Other plastic surgery in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →